Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|February 18, 2004
Facts, figures and trends in lead generationRebecca Deprez-Poulain, Benoit DeprezFuture Medicinal Chemistry|February 16, 2016
Kinetic target-guided synthesis in drug discovery and chemical biology: a comprehensive facts and figures surveyDamien Bosc, Jouda Jakhlal, Benoit Deprez, et al.Combinatorial Chemistry & High Throughput Screening|May 14, 2008
Alkylsquarates as key intermediates for the rapid preparation of original drug-inspired compoundsJulie Charton, Lise Charruault, Rebecca Deprez-Poulain, et al.Cells|April 12, 2022
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?Laetitia Lesire, Florence Leroux, Rebecca Deprez-Poulain, et al.Thrombosis and Haemostasis|July 8, 2016
ADAMTS5 promotes murine adipogenesis and visceral adipose tissue expansionDries Bauters, Ilse Scroyen, Rebecca Deprez-Poulain, et al.Bioorganic & Medicinal Chemistry Letters|July 23, 2003
Design, synthesis and antimalarial activity of novel, quinoline-based, zinc metallo-aminopeptidase inhibitorsMarian Flipo, Isabelle Florent, Philippe Grellier, et al.Chemical Biology & Drug Design|June 17, 2008
Natural compounds: leads or ideas? Bioinspired molecules for drug discoveryTerence Beghyn, Rebecca Deprez-Poulain, Nicolas Willand, et al.European Journal of Medicinal Chemistry|June 21, 2011
Application of Ullmann and Ullmann-Finkelstein reactions for the synthesis of N-aryl-N-(1H-pyrazol-3-yl) acetamide or N-(1-aryl-1H-pyrazol-3-yl) acetamide derivatives and pharmacological evaluationRebecca Deprez-Poulain, Nicolas Cousaert, Patrick Toto, et al.Chemmedchem|August 5, 2024
The French Medicinal Chemistry Society-SCT, an Historical Member of EFMCRebecca Deprez-Poulain, Maria Duca, Nicolas George, et al.Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivativesJulie Charton, Rebecca Deprez-Poulain, Nathalie Hennuyer, et al.Pageof 4